Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Trial
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
Clinical investigators need to look out for confounding and bias associated with real-world data in randomized trials and observational studies used to produce real-world evidence (RWE) to assess the safety and efficacy of an intervention.
March 17, 2023
Virtual reality may reduce pain, anxiety in children undergoing blood draws
Immersive virtual reality intervention for children undergoing blood draws significantly reduced pain and anxiety when compared with control groups in a study.
February 17, 2023
Labcorp expects to complete Clinical Development business spin-off by mid-year
The spin-off, named Fortrea, will provide Phases I through IV clinical trial management and commercialization solutions to pharmaceutical and biotechnology organizations globally.
February 9, 2023
AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
Capitainer's quantitative self-sampling product automatically separates cells from whole blood using a finger stick that can be done in a patient's home, potentially expanding access to individuals who would participate in clinical trials.
February 1, 2023
Unilabs, Ambry Genetics to provide genetic testing for biopharma firms in Europe, Latin America, Middle East
The companies aim to address one of the main challenges to the use of genomics in global clinical trials: a lack of standardization in laboratory testing protocols and analysis.
January 26, 2023
After Illumina presentation highlighting Grail potential comes a possible EU fine
At the J.P. Morgan healthcare event this week, Illumina's CEO said Grail must be operated separately and independently pursuant to measures required by the EU.
January 12, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
OpGen to prepare FDA de novo request, completes clinical trial for UTI panel
The completed trial evaluated the performance of the Unyvero UTI Panel for detecting urinary tract infections using clean-catch or catheter-related urine samples.
December 13, 2022
BillionToOne announces clinical data on NIPT for recessive conditions
The firm's Unity Screen is designed to assess fetal risk of recessive conditions such as cystic fibrosis, sickle cell disease, the thalassemias, and spinal muscular atrophy.
December 6, 2022
Reveal Genomics presents trial results for HER2Dx breast cancer test at SABCS
The results show that an HER2Dx risk score was significantly associated with relapse-free interval and long-term survival outcomes; additionally, HER2Dx can identify patients who might be candidates for neoadjuvants or de-escalation of systemic therapy.
December 6, 2022
Diadem presents data at CTAD on blood test for early prediction of Alzheimer's
The firm is preparing to launch a test next year that enables drug developers to identify with high confidence individuals who will experience a decline to Alzheimer's dementia up to six years in advance of diagnosis.
December 5, 2022
Global Health Innovative Technology obtains $20M grant over five years from Wellcome
GHIT said that in 2023, the tenth anniversary of its founding, it will aim to streamline and accelerate research and development for malaria, tuberculosis, neglected tropical diseases, and other infectious diseases.
December 5, 2022
Blood-based MDx test developer DiamiR to present poster on trial findings at CTAD
The poster will be presented during the session “Clinical trials: Biomarkers including plasma” during the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco from November 29 to December 2.
November 28, 2022
Page 1 of 16
Next Page
